DMD Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenberg, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenberg, D. W.

Pharmacokinetics of cobalt chloride and cobalt-protoporphyrin

DW Rosenberg

School of Pharmacy, University of Connecticut, Storrs 06268.

A comparison of the pharmacokinetics of the trace element cobalt and the protoporphyrin chelate of this metal, cobalt-protoporphyrin, was conducted in male Sprague-Dawley rats. Following subcutaneous treatment (250 mumol/kg body weight), cobalt was found predominantly (> 95%) in plasma, from which it was rapidly eliminated (t1/2 approximately 25 hr). Cobalt-protoporphyrin, also found almost exclusively in plasma (> 95%), exhibited a much slower elimination rate (approximately 3 days) in comparison to the noncomplexed metal. Four weeks after dosing with either inorganic cobalt or cobalt-protoporphyrin, tissue levels of cobalt were measured by graphite furnace atomic absorption spectroscopy. The kidney retained the highest levels of cobalt (1 and 4 micrograms/g dry tissue weight, respectively), although in cobalt- protoporphyrin-treated rats, elevated levels of cobalt (1.5 micrograms/g) were still observed in the spleen, gonads, lung, and thymus up to 4 weeks posttreatment. These differences in pharmacokinetics between inorganic cobalt and cobalt-protoporphyrin are discussed in terms of the differing biological properties exhibited by the metal in its different chemical associations.

Volume 21, Issue 5, pp. 846-849, 09/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 HypertensionHome page
T. Vera, S. Kelsen, and D. E. Stec
Kidney-Specific Induction of Heme Oxygenase-1 Prevents Angiotensin II Hypertension
Hypertension, October 1, 2008; 52(4): 660 - 665.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Matsumoto, Y. Makino, T. Tanaka, H. Tanaka, N. Ishizaka, E. Noiri, T. Fujita, and M. Nangaku
Induction of Renoprotective Gene Expression by Cobalt Ameliorates Ischemic Injury of the Kidney in Rats
J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1825 - 1832.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics.